These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 9106464
41. The possible involvement of endogenous ligands for mu-, delta- and kappa-opioid receptors in modulating morphine-induced CPP expression in rats. Liang J, Li Y, Ping X, Yu P, Zuo Y, Wu L, Han JS, Cui C. Peptides; 2006 Dec; 27(12):3307-14. PubMed ID: 17097192 [Abstract] [Full Text] [Related]
42. Effects of noribogaine on the development of tolerance to antinociceptive action of morphine in mice. Bhargava HN, Cao YJ. Brain Res; 1997 Oct 17; 771(2):343-6. PubMed ID: 9401754 [Abstract] [Full Text] [Related]
43. Effects of central administration of highly selective opioid mu-, delta- and kappa-receptor agonists on plasma luteinizing hormone (LH), prolactin, and the estrogen-induced LH surge in ovariectomized ewes. Walsh JP, Clarke IJ. Endocrinology; 1996 Sep 17; 137(9):3640-8. PubMed ID: 8756528 [Abstract] [Full Text] [Related]
44. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice. Wu HE, Sun HS, Terashivili M, Schwasinger E, Sora I, Hall FS, Uhl GR, Tseng LF. Eur J Pharmacol; 2006 Feb 15; 531(1-3):103-7. PubMed ID: 16445907 [Abstract] [Full Text] [Related]
46. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes. Cahill CM, White TD, Sawynok J. J Pharmacol Exp Ther; 1995 Oct 15; 275(1):84-93. PubMed ID: 7562600 [Abstract] [Full Text] [Related]
47. Peptide opioid antagonist separates peripheral and central opioid antitransit effects. Shook JE, Pelton JT, Hruby VJ, Burks TF. J Pharmacol Exp Ther; 1987 Nov 15; 243(2):492-500. PubMed ID: 2824748 [Abstract] [Full Text] [Related]
48. Acute cross-tolerance to opioids in heroin delta-opioid-responding Swiss Webster mice. Rady JJ, Fujimoto JM. J Biomed Sci; 2000 Nov 15; 7(3):258-69. PubMed ID: 10810246 [Abstract] [Full Text] [Related]
51. The effect of intrathecal mu, delta, kappa, and alpha-2 agonists on thermal hyperalgesia induced by mild burn on hind paw in rats. Kim HJ, Seol TK, Lee HJ, Yaksh TL, Jun JH. J Anesth; 2011 Dec 26; 25(6):884-91. PubMed ID: 21983967 [Abstract] [Full Text] [Related]
52. Induction of Fos-like immunoreactivity by opioids in guinea-pig brain. Bot G, Chahl LA. Brain Res; 1996 Aug 26; 731(1-2):45-56. PubMed ID: 8883853 [Abstract] [Full Text] [Related]
56. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice. Narita M, Mizoguchi H, Narita M, Sora I, Uhl GR, Tseng LF. Br J Pharmacol; 1999 Jan 13; 126(2):451-6. PubMed ID: 10077238 [Abstract] [Full Text] [Related]
57. Supraspinal administration of opioids with selectivity for mu-, delta- and kappa-opioid receptors produces analgesia in amphibians. Stevens CW, Rothe KS. Eur J Pharmacol; 1997 Jul 16; 331(1):15-21. PubMed ID: 9274924 [Abstract] [Full Text] [Related]
58. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes. Sofuoglu M, Portoghese PS, Takemori AE. J Pharmacol Exp Ther; 1991 May 16; 257(2):676-80. PubMed ID: 1851833 [Abstract] [Full Text] [Related]